Drugs: Pressemitteilungen - Kategorie - Seite 36

Drugs

Category / Pharmaceuticals & Biotech / Drugs


Medical Pharmacies Group Acquires Desjardins Healthcare Group to Expand Its Offerings and Enhance Value to Customers

PICKERING, ONTARIO: Combination Will Create a Leading National Provider of Pharmacy Services and Healthcare Products Serving Residents in Long Term Care Facilities, Retirement Homes and the Community ...

Itonis Pharmaceuticals and Charles Hensley, Ph.D. to Begin Distributing Emesyl(TM) Anti-Nausea Homeopathic Product in Mexico

LAGUNA HILLS, CA: LAGUNA HILLS, CA -- (Marketwired) -- 09/12/13 -- Itonis, Inc.'s pharmaceutical division (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam® Cold Remedy, are pleased to ann ...

Axxess Pharma Inc. President, Daniel Bagi, M.D. Provides Exclusive Interview on StockTradersTalk.com

TORONTO: TORONTO -- (Marketwired) -- 09/12/13 -- Axxess Pharma Inc -- (PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional supplements company -- is pleased to announce its President, Daniel Bagi, M. ...

Sirona Announces Private Placement

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 09/11/13 -- Sirona Biochem Corp. (TSX VENTURE: SBM)(OTCQX: SRBCF)(FRANKFURT: ZSB) (the "Company") is pleased to announce that it has arrange ...

/ CORRECTION - Flamel Technologies Announces Acceptance of FDA Review for Second NDA

LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 09/11/13 -- In the news release, "Flamel Technologies Announces Acceptance of FDA Review for Second NDA," issued earlier today by Flamel Technologies (NASDA ...

Flamel Technologies Announces Acceptance of FDA Review for Second NDA

LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 09/11/13 -- Flamel Technologies S.A. (NASDAQ: FLML) today announced that the US Food and Drug Administration (FDA) has accepted for review the Company's second n ...

Phase 3 Data From The Medicines Company's Oritavancin Solo Trials Featured at ICAAC Conference

DENVER, CO: Positive Results for Solo I and Solo II Trial of Oritavancin in Acute Bacterial Skin and Skin Structure Infections Including MRSA ...

Trading in Theravance Common Stock Halted

SOUTH SAN FRANCISCO, CA: FDA Advisory Committee to Review ANORO(TM) ELLIPTA(TM) NDA ...

NuPathe Announces Allowance of Additional U.S. Patent for ZECUITY

CONSHOHOCKEN, PA: CONSHOHOCKEN, PA -- (Marketwired) -- 09/10/13 -- (NASDAQ: PATH) today announced that the United States Patent and Trademark Office has issued a notice of allowance for U.S. Patent application 13/407 ...

AXXESS Pharma Inc. Signs Agreement With Top Mexican Pharmaceutical Company

TORONTO, ON: TORONTO, ON -- (Marketwired) -- 09/09/13 -- Axxess Pharma Inc. (PINKSHEETS: AXXE), a specialty pharmaceutical and nutritional supplements company, is pleased to announce they have signed an agreement ...

Boston Therapeutics Closes on Approximately $3.5 Million in Private Placement of Common Stock and Warrants

MANCHESTER, NH: MANCHESTER, NH -- (Marketwired) -- 09/09/13 -- Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), a developer of drugs based on complex carbohydrate ...

Vital Therapies, Inc. Expands Executive Team

SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwired) -- 09/06/13 -- Vital Therapies®, Inc. (VTI), a biopharmaceutical company developing a cell-based therapy targeting the treatment of acute liver failure, today announce ...

Threshold Pharmaceuticals Announces Presentation and Webcast at the Stifel Healthcare Conference 2013

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 09/05/13 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Barry Selick, Ph.D., Threshold's Chief Executive Officer, will present ...

Axxess Pharma Inc. Announces US Board Certified Cardiologist, Dr. Fred Maese as Senior Consultant

TORONTO, ON: Dr. Maese Brings Forth Strong Medical Following via His Established Radio Shows ...

NuPathe to Present at the Stifel 2013 Healthcare Conference

CONSHOHOCKEN, PA: CONSHOHOCKEN, PA -- (Marketwired) -- 09/04/13 -- (NASDAQ: PATH) will present a company overview at the Stifel 2013 Healthcare Conference on Wednesday, September 11, 2013, at 4:25 p.m. EDT. The confe ...

Axxess Pharma Inc. Announces MOU to Acquire Leading Canadian OTC Healthcare Company

TORONTO, ON: TORONTO, ON -- (Marketwired) -- 09/02/13 -- Axxess Pharma Inc. (PINKSHEETS: AXXE), a specialty pharmaceutical and nutritional supplements company, today announced an Agreement in Principle to acquire ...

International Stem Cell Corporation to Present at Rodman & Renshaw 15th Annual Global Investment Conference September 8th to 10th

CARLSBAD, CA: CARLSBAD, CA -- (Marketwired) -- 08/28/13 -- International Stem Cell Corporation (OTCQB: ISCO) (), a California-based biotechnology company developing novel stem cell based therapies and biomedical p ...

Congenia S.R.L.: Enrollment of First Healthy Volunteer in Phase 1

MILAN, ITALY: MILAN, ITALY -- (Marketwired) -- 08/27/13 --Contacts: RNS Customer Services 0044-207797-4400 ...

Xylitol Canada Inc. Financial Results for Three and Six Months Ended June 30, 2013

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 08/19/13 -- Xylitol Canada Inc. ("Xylitol Canada", or the "Company") (TSX VENTURE: XYL) today announces that it has released its financial an ...

Seragon Pharmaceuticals Launched, Focused on Selective Estrogen Receptor Degrader Platform (SERD)

SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwired) -- 08/19/13 -- Seragon Pharmaceuticals Inc. today announced its formation and the closing of its Series A financing. Seragon is focused on developing new treatments for ...


Seite 36 von 66:  « ..  35 36 37  38  39  40  41  42  43  44  .. » 66





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z